What's Happening With These Health Care Plans Stocks? -- Aetna, Anthem, Centene, and Cigna

Thursday, April 26, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 26, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment

community. Today we are offering reports on AET, ANTM, CNC, and CI which can be accessed for free by signing up to www.wallstequities.com/registration. On Wednesday, April 25, 2018, the Dow Jones Industrial Average and
the S&P 500 edged 0.25% and 0.18% higher, respectively at the closing bell, while the NASDAQ Composite stayed bearish, finishing marginally lower by 0.05%. US markets saw four out of nine sectors finishing the day in red, three in green, and two in neutral territory. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Health Care Plans equities this morning: Aetna Inc. (NYSE: AET), Anthem Inc. (NYSE: ANTM), Centene Corp. (NYSE: CNC), and Cigna Corp. (NYSE: CI). All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration

Aetna

On Wednesday, shares in Hartford, Connecticut-based Aetna Inc. recorded a trading volume of 1.21 million shares. The stock ended at $178.99, rising 1.01% from the last trading session. The Company's shares have gained 33.74% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 2.60% and 5.40%, respectively. Furthermore, shares of Aetna, which operates as a health care benefits company in the US, have a Relative Strength Index (RSI) of 66.10. Get the full research report on AET for free by clicking below at: www.wallstequities.com/registration/?symbol=AET

Anthem

Indianapolis, Indiana headquartered Anthem Inc.'s stock finished yesterday's session 6.15% higher at $238.84. A total volume of 3.74 million shares was traded, which was above their three months average volume of 1.62 million shares. The Company's shares have gained 38.49% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 4.60% and 11.58%, respectively. Furthermore, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US, have an RSI of 63.23. Today's complimentary research report on ANTM is accessible at: www.wallstequities.com/registration/?symbol=ANTM

Centene

At the close of trading on Wednesday, shares in St. Louis, Missouri headquartered Centene Corp. saw a rise of 1.44%, ending the day at $109.29. The stock recorded a trading volume of 1.98 million shares, which was higher than its three months average volume of 1.49 million shares. The Company's shares have advanced 48.80% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 4.88% and 12.63%, respectively. Moreover, shares of Centene, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have an RSI of 55.60. Sign up for free on Wall St. Equities and claim the latest report on CNC at: www.wallstequities.com/registration/?symbol=CNC

Cigna

Bloomfield, Connecticut headquartered Cigna Corp.'s shares ended the day 0.24% higher at $171.70 with a total trading volume of 1.29 million shares. The stock has gained 9.24% over the last twelve months. The Company's shares are trading below their 50-day moving average by 3.23%. Additionally, shares of Cigna, which provides insurance and related products and services in the US and internationally, have an RSI of 45.99. See the free research coverage on CI at: www.wallstequities.com/registration/?symbol=CI

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

 

Cision View original content:http://www.prnewswire.com/news-releases/whats-happening-with-these-health-care-plans-stocks----aetna-anthem-centene-and-cigna-300637138.html

SOURCE Wall St. Equities



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store